Skip to main content

Table 3 Multivariate Cox analyses of treatment methods for OS (n = 21,030)

From: Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis

TNM Stage

Treatments

Multivariate HR (95% CI)

P value

T1-3N0M0

  

0.001

 

Only surgery

Reference

 
 

Surgery + chemotherapy

0.896(0.827–0.970)

0.007

 

Neoadjuvant radiotherapy

1.171(1.019–1.347)

0.027

 

Adjuvant radiotherapy

0.950(0.874–1.032)

0.223

T1-3N + M0

  

< 0.001

 

Only surgery

Reference

 
 

Surgery + chemotherapy

0.686(0.649–0.726)

< 0.001

 

Neoadjuvant radiotherapy

0.751(0.635–0.887)

0.001

 

Adjuvant radiotherapy

0.613(0.579–0.649)

< 0.001

T4N0M0

  

< 0.001

 

Only surgery

Reference

 
 

Surgery + chemotherapy

0.588(0.424–0.814)

0.001

 

Neoadjuvant radiotherapy

0.482(0.347–0.670)

< 0.001

 

Adjuvant radiotherapy

0.858(0.621–1.185)

0.353

T4N + M0

  

< 0.001

 

Only surgery

Reference

 
 

Surgery + chemotherapy

0.530(0.411–0.683)

< 0.001

 

Neoadjuvant radiotherapy

0.338(0.215–0.532)

< 0.001

 

Adjuvant radiotherapy

0.430(0.334–0.554)

< 0.001

  1. OS Overall Survival, CI Confidence intervals, HR Hazard ratios